Sandoz Group AG SDZNY SDZXF on Monday filed an antitrust lawsuit in the U.S. against Amgen, Inc. AMGN for extending and entrenching the dominant market position of its blockbuster medicine, Enbrel ...

ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen over the alleged entrenchment of the market position of ...

ZURICH, April 14 (Reuters) - Swiss generic drug manufacturer Sandoz (SDZ.S), opens new tab said on Monday it had filed an antitrust lawsuit in the United States against Amgen (AMGN.O), opens new ...

Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group.

Sandoz drugs Jubbonti and Wyost are approved for use in all indications covered by the Amgen products, Prolia and Xgeva. But no launch date is planned yet, due to ongoing patent litigation between ...

The annual eGFR chronic slope (week 6 to 108) declined less in the sparsentan arm than irbesartan arm (-4.8 vs -5.7 mL/min/1.73 m 2) but the 0.9 mL/min/1.73 m 2 difference was not significant.

Sandoz shares dipped on their market debut on Wednesday after the generic and biosimilar drugmaker was valued at a lower-than-expected 10.3 billion Swiss francs ($11.2 billion) in its spin-off ...

Sandoz shares (SDZ) to be listed and traded on SIX Swiss Exchange; ADRs to be traded on OTCQX®, first trading day October 4, 2023Sandoz to be included in key Swiss market indicesInvestment grade ...